Inmunomodulación y Microambiente Tumoral
ITAM
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoGlaxoSmithKline (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
1997
-
Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus
Hepatology, Vol. 25, Núm. 2, pp. 470-477